Insider Trading History of Treco Douglas A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Treco Douglas A since 2019. This trader's CIK number is 1688192. At the time of last reporting, Treco Douglas A was the CEO of Inozyme Pharma, Inc.. (stock ticker symbol INZY). Also see all insider trading activities at Inozyme Pharma, Inc..

Note that in the past Treco Douglas A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Ra Pharmaceuticals, Inc. (RARX) by Treco Douglas A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 RARX 0 $0 0 $0 20,834 $0

Yearly summary of insider trading at Inozyme Pharma, Inc. (INZY) by Treco Douglas A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 INZY 0 $0 7,523 $52,209 25,000 $0


Insider trading activities at 2 companies by Treco Douglas A:

1. Ra Pharmaceuticals, Inc. (RARX)

2. Inozyme Pharma, Inc. (INZY)

Table 1. Insider trading of Ra Pharmaceuticals, Inc. (RARX) by Treco Douglas A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-02-01 RARX Option Ex 20,834 .00 0

Table 2. Insider trading of Inozyme Pharma, Inc. (INZY) by Treco Douglas A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-04-02 INZY Sale 7,523 6.94 52,209
2024-04-01 INZY Option Ex 25,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Treco Douglas A (CEO of Inozyme Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.